Ablation catheter receives 510(K) clearance:
This article was originally published in Clinica
Biosense Webster has received 510(K) clearance for its Celsius II Bi-Directional Ablation Catheter for cardiac mapping and ablation. The design provides directional control with a handle and tip that respond simultaneously, simplicity and speed. The device gives electrophysiologists access to a diagnostic and ablation tool enable control in an anatomical situation or constraint.
You may also be interested in...
ConMed Corp. is company of two halves ̶ general surgery and orthopedics – and is readying itself for a renewed assault on these two markets on the back of a technology pipeline, targeted acquisitions and a new growth-winning culture, says CFO Todd Garner.
Drug pricing and access issues expose the pharmaceutical sector especially acutely to calls for companies to meet ethical and social goals, alongside commercial ones. Digital is up-ending pharma’s processes, its workplaces and its consumers. R&D productivity is spluttering. Amid this turmoil, CEOs highlight company culture – the way an organization behaves – as a crucial ingredient for success. But what is a “right” culture? Organizational culture is neither static nor singular. It is continuously influenced by acquisitions, markets, new technologies and new generations. And pharma’s history suggests that culture change cannot happen without sufficient people change.